EcoDrugPlus

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSVVUG00000009718
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSVVUG00000015079
Gene Symbol: AVPR1A
1 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSVVUG00000013571
Gene Symbol: AVPR1B
3 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSVVUG00000029607
Gene Symbol: AVPR2
3 Cross references
231 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSVVUG00000008606
Gene Symbol: AHR
3 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSVVUG00000017355
Gene Symbol: AURKA
3 Cross references
228 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSVVUG00000028115
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSVVUG00000002429
Gene Symbol: AURKC
3 Cross references
96 Possible Orthologues:

Bcl-2-Related Protein A1-Like

Ensembl ID : ENSVVUG00000004284
Gene Symbol: LOC112923323
2 Cross references
114 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSVVUG00000024709
Gene Symbol: BACE1
3 Cross references
217 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSVVUG00000028046
Gene Symbol: BDKRB1
3 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSVVUG00000028044
Gene Symbol: BDKRB2
3 Cross references
356 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).